Skip to main content

Table 1 Study outcomes, measures, and patient characteristics

From: Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease

No.

Outcomes, Measures & Characteristics

Data Source by Outcome

Timeline and Frequency

Baseline Pre-Visit

Post-Visit

Three Months

1

Primary Outcome

Patient Knowledge

   
 

Anemia Knowledge

Patient Anemia Knowledge in Kidney Disease (PAKKD) [19]

X

X

X

2

Secondary Outcomes

Patient Satisfaction

   
 

Provider Communication Satisfaction

Satisfaction with Provider Communications (CAT) [20]

 

X

 
 

Health Decision Certainty

Decisional Conflict Scale (DCS) [21]

 

X

 
 

Perceived Communication Efficacy

Perceived Efficacy in Patient-Physician Interactions (PEPPI) [22]

 

X

X

3

Subject Characteristics

Potential Co-Variables/Modifiers

   
 

Patient Demographic Information

Demographic Form

X

 

X

 

Patient Numeracy Assessments

Schwartz Risk Numeracy Test [27]

X

  
 

Anemia Symptoms

Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) [28]

X

 

X

 

Medical Outcomes

Patient Electronic Medical Record Hemoglobin Lab Values

X

 

X